About: Prevalence and Prognostic Impact of Subclinical Cardiovascular Disease in Individuals With the Metabolic Syndrome and Diabetes

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Prevalence and Prognostic Impact of Subclinical Cardiovascular Disease in Individuals With the Metabolic Syndrome and Diabetes Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article by Erik Ingelsson et al published 16 March 2007 in Diabetes

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в березні 2007 (uk) article scientifique publié en 2007 (fr) im März 2007 veröffentlichter wissenschaftlicher Artikel (de) article by Erik Ingelsson et al published 16 March 2007 in Diabetes (en)
publication date	wds:Q57072996-1607AB6E-9BA0-426F-B82E-B3FEE4E72235
publication date	2007-03-16 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57072996-67833988-201D-4F9F-8500-619927F6AC84
language of work or name	English
author name string	wds:Q57072996-0547AE0B-EA07-4382-83FC-1E973A255ADA wds:Q57072996-07E2CAAB-D401-4682-9103-F942CA54B420 wds:Q57072996-2BB0267F-4CF0-4EA5-9C90-F4D3F1E20C68 wds:Q57072996-D13B9FD0-E004-4E55-A21C-DE47ED950308
author name string	T. J. Wang J. M. Murabito L. M. Sullivan C. J. O'Donnell
rdfs:label	Prevalence and Prognostic Impact of Subclinical Cardiovascular Disease in Individuals With the Metabolic Syndrome and Diabetes (en) Prevalence and Prognostic Impact of Subclinical Cardiovascular Disease in Individuals With the Metabolic Syndrome and Diabetes (nl)
skos:prefLabel	Prevalence and Prognostic Impact of Subclinical Cardiovascular Disease in Individuals With the Metabolic Syndrome and Diabetes (en) Prevalence and Prognostic Impact of Subclinical Cardiovascular Disease in Individuals With the Metabolic Syndrome and Diabetes (nl)
name	Prevalence and Prognostic Impact of Subclinical Cardiovascular Disease in Individuals With the Metabolic Syndrome and Diabetes (en) Prevalence and Prognostic Impact of Subclinical Cardiovascular Disease in Individuals With the Metabolic Syndrome and Diabetes (nl)
author	wds:Q57072996-10055D4D-8A45-4168-98B9-2C56F8F0D161 wds:Q57072996-1783913F-2D4F-439D-9382-0F49B4208E5F wds:Q57072996-38F20682-350C-44D0-A313-89339F3FAB5A wds:Q57072996-6DD11AF6-EDC9-4914-8250-BBD4BD3F38D2 wds:Q57072996-B9FFFF0B-DB48-4CD6-8F18-E4E7D8444CE6 wds:Q57072996-BEF8F4A3-DE89-4D00-ACD4-18FA3B0ADCA4 wds:Q57072996-D504B448-23BD-485D-8CC0-0AE3C5E7D305 wds:Q57072996-F35AAC14-3CE2-4A92-B32C-031056AFD051 wds:Q57072996-F5DA11FB-751F-4335-BF4C-D87598606D06
author	Emelia J. Benjamin Ralph B. D'Agostino Sr. Caroline S. Fox James B. Meigs Erik Ingelsson Michelle J. Keyes Ramachandran S. Vasan Joseph F Polak Philip A Wolf
title	wds:Q57072996-7EF57707-9B90-4B96-87DC-B77062967975
title	Prevalence and Prognostic Impact of Subclinical Cardiovascular Disease in Individuals With the Metabolic Syndrome and Diabetes (en)
page(s)	wds:Q57072996-53343CCF-CA1F-4FA5-AE09-455EF247E0DC
page(s)	1718-1726
instance of	wds:Q57072996-BCDCC213-7986-435C-A906-9463F27BFC5D
instance of	scholarly article
main subject	wds:Q57072996-0D72BF92-B38C-4CCD-9847-A04AA97B6D39 wds:Q57072996-C59822A6-10B8-4F8B-9201-0C92CA83BF6D
main subject	cardiovascular disease metabolic syndrome
PubMed ID	wds:Q57072996-66153C4F-4FC8-4922-BE8B-B503E17D29D4
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17369522
PubMed ID	17369522
published in	wds:Q57072996-95A7C2E6-8D0B-4EE7-999E-F308D8512DA4
published in	Diabetes
issue	wds:Q57072996-E9FD6C60-226D-4919-AFC2-B56B0775D6CC
volume	wds:Q57072996-D7C03477-A8B9-4C29-BE81-41C796A022B7
issue	6
volume	56
DOI	wds:Q57072996-7F11ECEA-6DEF-463D-9CBF-CB1A03BA7DB5
DOI	http://dx.doi.org/10.2337/DB07-0078
DOI	10.2337/DB07-0078
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q57072996
is cites work of	Defining and achieving treatment success in patients with type 2 diabetes mellitus Subclinical atherosclerosis: what it is, what it means and what we can do about it. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications The association between physical activity and both incident coronary artery calcification and ankle brachial index progression: the multi-ethnic study of atherosclerosis Central versus peripheral cardiovascular risk in metabolic syndrome Common variants in and near IRS1 and subclinical cardiovascular disease in the Framingham Heart Study Distribution and clinical correlates of the interleukin receptor family member soluble ST2 in the Framingham Heart Study Endothelial nitric oxide synthetase genetic variants, metabolic syndrome and endothelial function in schizophrenia Modulation of adipose tissue lipolysis and body weight by high-density lipoproteins in mice Atherosclerosis and cardiac function assessment in low-density lipoprotein receptor-deficient mice undergoing body weight cycling Association between Retinal Arteriolar and Venule Calibre with Prevalent Heart Failure: A Cross-Sectional Study Definition of intervention points in prediabetes. Metabolic syndrome as a predictor of type 2 diabetes, and its clinical interpretations and usefulness Metabolic syndrome, cardiovascular risk and screening for subclinical atherosclerosis Metabolic syndrome in hypertensive patients: An unholy alliance Impact of the metabolic syndrome on the predictive values of new risk markers in the general population Development and Validation of Risk Prediction Models for Cardiovascular Events in Black Adults: The Jackson Heart Study Cohort Relations between subclinical disease markers and type 2 diabetes, metabolic syndrome, and incident cardiovascular disease: the Jackson Heart Study Angiopoietin-2, its soluble receptor Tie-2, and metabolic syndrome components in a population-based sample Metabolic syndrome and endothelial fibrinolytic capacity in obese adults. Management of the metabolic syndrome in cardiovascular disease Metabolic syndrome, strain, and reduced myocardial function: multi-ethnic study of atherosclerosis. Searching for novel PET radiotracers: imaging cardiac perfusion, metabolism and inflammation Plasma aldosterone and its relationships with left ventricular mass in essential hypertensive patients with the metabolic syndrome. Residual cardiovascular risk in individuals on lipid-lowering treatment: quantifying absolute and relative risk in the community. Aged Garlic Extract Reduces Low Attenuation Plaque in Coronary Arteries of Patients with Metabolic Syndrome in a Prospective Randomized Double-Blind Study. Natural History of Obesity sub-phenotypes: Dynamic changes over two decades and prognosis in The Framingham Heart Study Premature cardiac contractions and risk of incident ischemic stroke. Association of exhaled carbon monoxide with subclinical cardiovascular disease and their conjoint impact on the incidence of cardiovascular outcomes Metabolic syndrome in patients with hematological diseases. Twenty-Year Trends in the American Heart Association Cardiovascular Health Score and Impact on Subclinical and Clinical Cardiovascular Disease: The Framingham Offspring Study. Aerobic interval training reduces vascular resistances during submaximal exercise in obese metabolic syndrome individuals A community-based exercise intervention transitions metabolically abnormal obese adults to a metabolically healthy obese phenotype Endothelial vasodilator function in normal-weight adults with metabolic syndrome Association of a 62 Variants Type 2 Diabetes Genetic Risk Score With Markers of Subclinical Atherosclerosis: A Transethnic, Multicenter Study.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software